HCA Healthcare, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for HCA Healthcare, Inc. (HCA), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are HCA insiders buying or selling?
In the last 12 months, HCA Healthcare, Inc. insiders reported 0 open-market purchases ($0) and 6 sales ($31.1M) — net selling of $31.1M. Since January 2018, Trabud has recorded 202 Form 4 filings for HCA: 8 buys ($25.3M) and 194 sells ($463.7M).
Source: SEC EDGAR Form 4
What stands out
- No HCA Healthcare, Inc. insider made an open-market purchase in the last 12 months; the 6 reported open-market sales totaled $31.1M.
Key Statistics (January 2018 – Feb 19, 2026)
Total Form 4 filings
202
SEC EDGAR
Insider filers
35
Insider buys (8)
$25.3M
Insider sells (194)
$463.7M
Insider sentiment
Net sellingNet insider flow of $438.4M in net selling since January 2018, and $31.1M in net selling over the last 12 months.
Recent HCA insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Feb 19, 2026 | Michael R Mcalevey | EVP & Chief Legal & Admin Off. | Sale | 1.7K | $533.37 | $903.5K | SEC ↗ |
| Feb 12, 2026 | Christopher F. Wyatt | SVP & Controller | Sale | 4.0K | $505.00 | $2.0M | SEC ↗ |
| Feb 12, 2026 | Jennifer Berres | SVP & Chief Human Res. Officer | Sale | 8.0K | $514.58 | $4.1M | SEC ↗ |
| Feb 5, 2026 | Samuel N Hazen | CEO | Sale | 42.9K | $501.04 | $21.5M | SEC ↗ |
| Feb 5, 2026 | Michael S. Cuffe | EVP and Chief Clinical Officer | Sale | 1.5K | $498.09 | $747.1K | SEC ↗ |
| Nov 5, 2025 | Michael R Mcalevey | EVP & Chief Legal & Admin Off. | Sale | 3.9K | $473.79 | $1.8M | SEC ↗ |
| Sep 8, 2025 | Michael S. Cuffe | EVP and Chief Clinical Officer | Sale | 3.8K | $418.84 | $1.6M | SEC ↗ |
| May 15, 2025 | Jon M Foster | EVP and COO | Sale | 15.7K | $369.32 | $5.8M | SEC ↗ |
| Mar 28, 2025 | BANK OF AMERICA CORP /DE | 10% Owner | Purchase | 258 | $32.53 | $8.4K | SEC ↗ |
| Feb 19, 2025 | Jennifer Berres | SVP & Chief Human Res. Officer | Sale | 9.5K | $322.59 | $3.1M | SEC ↗ |
| Nov 18, 2024 | Kathleen M Whalen | SVP & Chief Ethics Officer | Sale | 1.5K | $357.99 | $527.7K | SEC ↗ |
| Nov 14, 2024 | Phillip G Billington | SVP-Internal Audit Services | Sale | 3.9K | $350.00 | $1.4M | SEC ↗ |
| Nov 14, 2024 | Erol R Akdamar | Group President | Sale | 2.9K | $353.00 | $1.0M | SEC ↗ |
| Sep 12, 2024 | Michael S. Cuffe | EVP and Chief Clinical Officer | Sale | 8.4K | $385.42 | $3.2M | SEC ↗ |
| Jul 31, 2024 | Kathleen M Whalen | SVP & Chief Ethics Officer | Sale | 4.9K | $362.13 | $1.8M | SEC ↗ |
| Jul 31, 2024 | Deborah M Reiner | SVP - Mktg. & Communications | Sale | 3.3K | $359.96 | $1.2M | SEC ↗ |
| Jul 29, 2024 | Christopher F. Wyatt | SVP & Controller | Sale | 4.0K | $360.20 | $1.4M | SEC ↗ |
| Jul 29, 2024 | Kathryn A. Torres | SVP-Payer Contracting & Align. | Sale | 1.9K | $355.05 | $659.3K | SEC ↗ |
| May 20, 2024 | Kathleen M Whalen | SVP & Chief Ethics Officer | Sale | 3.2K | $326.30 | $1.0M | SEC ↗ |
| May 17, 2024 | Kathryn A. Torres | SVP-Payer Contracting & Align. | Sale | 1.9K | $326.18 | $607.7K | SEC ↗ |
| May 13, 2024 | Michael S. Cuffe | EVP and Chief Clinical Officer | Sale | 6.3K | $316.88 | $2.0M | SEC ↗ |
| May 13, 2024 | Jeffrey E. Cohen | SVP-Government Relations | Sale | 1.6K | $313.00 | $516.5K | SEC ↗ |
| May 8, 2024 | Michael S. Cuffe | EVP and Chief Clinical Officer | Sale | 1.6K | $309.00 | $494.4K | SEC ↗ |
| May 6, 2024 | Kathryn A. Torres | SVP-Payer Contracting & Align. | Sale | 1.9K | $312.00 | $581.3K | SEC ↗ |
| Mar 20, 2024 | Chad J Wasserman | SVP and CIO | Sale | 1.2K | $327.92 | $400.1K | SEC ↗ |
Showing the 25 most recent of 202 Form 4 filings for HCA Healthcare, Inc..
Most active HCA insiders
- Kathryn A. Torres17 filings
- Michael S. Cuffe17 filings
- Kathleen M Whalen15 filings
- Deborah M Reiner14 filings
- Martin P. Paslick14 filings
Ask anything about HCA insider activity
Use Trabud's AI agent to query HCA Healthcare, Inc.'s Form 4 history in plain English — "Show me HCA CEO purchases this year" or compare it against any other ticker.
Open the AI agentHCA insider trading FAQ
Are HCA Healthcare, Inc. insiders buying or selling?
In the last 12 months, HCA Healthcare, Inc. insiders reported 0 open-market purchases ($0) and 6 sales ($31.1M) — net selling of $31.1M. Since January 2018, Trabud has recorded 202 Form 4 filings for HCA: 8 buys ($25.3M) and 194 sells ($463.7M). Over the full record that is net selling of $438.4M.
How many insiders trade HCA stock?
35 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for HCA Healthcare, Inc.. The most recent filing was accepted on Feb 19, 2026.
Where does Trabud get HCA insider trading data?
All HCA insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.